Anti-ceacam5 antibodies and conjugates and uses thereof
NZ835982APending Publication Date: 2026-08-28MERCK PATENT GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ835982
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-09-10
- Filing Date
- 2021-08-13
- Publication Date
- 2026-08-28
Smart Images
Figure 00000108_0000 
Figure 00000108_0001 
Figure 00000109_0000
Abstract
The invention provides antibodies which bind human CEACAM5 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding said antibodies. The invention also provides immunoconjugates comprising said antibodies linked to a growth-inhibitory agent, and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. The invention also provides use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.
Need to check novelty before this filing date? Find Prior Art